EGM
AXSM icon

Engineers Gate Manager’s Axsome Therapeutics AXSM Stock Holding History

Engineers Gate Manager’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.74M Sell
11,198
-5,186
-32% -$1.12M 0.04% 560
2026
Q1 		$2.77M Sell
16,384
-9,671
-37% -$1.67M 0.03% 584
2025
Q4 		$4.76M Buy
26,055
+13,877
+114% +$1.94M 0.06% 360
2025
Q3 		$1.48M Sell
12,178
-4,478
-27% -$504K 0.02% 944
2025
Q2 		$1.74M Sell
16,656
-7,633
-31% -$808K 0.02% 801
2025
Q1 		$2.83M Buy
24,289
+17,599
+263% +$2M 0.05% 558
2024
Q4 		$566K Buy
6,690
+1,493
+29% +$137K 0.01% 1346
2024
Q3 		$467K Buy
+5,197
New +$454K 0.01% 1407
2021
Q3 		– Sell
-18,039
Closed -$1.22M – 1639
2021
Q2 		$1.22M Buy
18,039
+7,167
+66% +$430K 0.08% 349
2021
Q1 		$616K Buy
10,872
+2,516
+30% +$177K 0.03% 861
2020
Q4 		$681K Buy
+8,356
New +$625K 0.03% 787
2020
Q3 		– Sell
-5,285
Closed -$435K – 1666
2020
Q2 		$435K Sell
5,285
-4,299
-45% -$331K 0.02% 1023
2020
Q1 		$564K Buy
+9,584
New +$781K 0.04% 697

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Engineers Gate Manager's AXSM Position: Q2 2026 in Review

Engineers Gate Manager reduced its Axsome Therapeutics (AXSM) stake by 32% in Q2 2026, selling an estimated $1.12M and leaving 11,198 shares worth $2.74M. The position accounts for 0.04% of the portfolio, ranked #560.

Engineers Gate Manager first reported a position in AXSM in Q1 2020 and has held it in 13 quarters since. The position peaked at $4.76M in Q4 2025. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Engineers Gate Manager held 11,198 shares of Axsome Therapeutics worth $2.74M as of Q2 2026.
  • Engineers Gate Manager sold 5,186 Axsome Therapeutics shares in Q2 2026, an estimated $1.12M.
  • Axsome Therapeutics made up 0.04% of Engineers Gate Manager's portfolio in Q2 2026, its #560 holding.
  • Engineers Gate Manager first reported a position in Axsome Therapeutics in Q1 2020 and has held it in 13 quarters since.
  • Engineers Gate Manager's Axsome Therapeutics position peaked at $4.76M in Q4 2025.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.